Calamos Advisors LLC Oramed Pharmaceuticals Inc. Transaction History

Calamos Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$5.88 - $12.03 $86,706 - $177,394	14,746 New	14,746 $0
Q2 2022 Aug 01, 2022	SELL	$3.72 - $9.0 $141,624 - $342,639	-38,071 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$8.19 - $13.89 $601,539 - $1.02 Million	-73,448 Reduced 65.86%	38,071 $330,000
Q4 2021 Feb 01, 2022	SELL	$12.98 - $29.75 $267,725 - $613,623	-20,626 Reduced 15.61%	111,519 $1.59 Million
Q3 2021 Oct 26, 2021	BUY	$12.13 - $23.82 $1.6 Million - $3.15 Million	132,145 New	132,145 $2.91 Million

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.